ESPR
Esperion Therapeutics Inc
3.20$
+0.0%
vs. previous close
Closing price · As of: Jul 15, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +47.5% | +6.8% | +2.4% | +2.7% | +20.4% | +71.5% | +11.9% | -18.3% | -67.2% | -61.6% | +66.7% | |
| – | +245.9% | +25.4% | +16.6% | +28.8% | +8.0% | +9.7% | -14.4% | -37.4% | -21.4% | +0.3% | -17.7% | |
| – | +244.3% | +24.9% | +16.6% | +28.8% | +8.0% | +9.7% | -23.7% | -29.8% | – | – | – | |
| – | -932.3% | – | +65.0% | +77.1% | -125.0% | – | – | – | – | -542.6% | – | |
| – | -62.8% | -71.1% | -79.8% | +694.7% | +531.1% | +1,302.8% | -100.0% | – | – | – | -40.4% | |
| – | +337.4% | – | -454.3% | – | -54.3% | -66.8% | -336.4% | – | +424.4% | -100.7% | – | |
| – | – | – | – | – | – | – | -100.0% | – | – | – | – | |
| – | +107.3% | -100.0% | +366,937.8% | -92.9% | +0.2% | -567.3% | – | -59.2% | – | – | – | |
| – | -113.2% | +151.4% | +6.5% | -38.6% | – | -19.4% | -100.2% | -100.0% | – | – | -256.8% | |
| – | +96.2% | -100.8% | – | -93.5% | +1,173.6% | +48.1% | +33.0% | -87.8% | +54.8% | +71.4% | -58.2% | |
| – | -127.0% | – | – | – | +5,093.0% | +6.0% | -133.4% | – | – | – | -63.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: July 15, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.